Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

05 juin 2017 08h00 HE | Source: OpGen, Inc.

OpGen Data at ASM Microbe 2017 Demonstrates Potential of Acuitas Products for Predicting Antibiotic Susceptibility and Infection Control

GAITHERSBURG, Md., June 05, 2017 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ:OPGN) today announced the results from additional studies supporting the capabilities of its Acuitas Rapid Test and Acuitas...
30 mai 2017 08h00 HE | Source: OpGen, Inc.

OpGen to Receive Ignaz Semmelweis Award for Commitment to Combatting Infection Deaths

GAITHERSBURG, Md., May 30, 2017 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ:OPGN) announced today that they will be recognized with the 2nd annual Ignaz Semmelweis Award for their commitment to safe...
25 mai 2017 08h00 HE | Source: OpGen, Inc.

OpGen to Present Advancements in Antibiotic Susceptibility and Whole Genome Sequencing at ASM Microbe 2017

GAITHERSBURG, Md., May 25, 2017 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ:OPGN) today announced that data on its Acuitas® Rapid Test in development and Acuitas Whole Genome Sequence Analysis will be...
27 avr. 2017 08h00 HE | Source: OpGen, Inc.

OpGen Appoints Tina S. Nova, Ph.D. to Board of Directors

GAITHERSBURG, Md., April 27, 2017 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ:OPGN) today announced that Tina S. Nova, Ph.D. has been appointed to its Board of Directors. Dr. Nova is a life...
26 avr. 2017 16h00 HE | Source: OpGen, Inc.

OpGen Announces 2017 First Quarter Financial Results

GAITHERSBURG, Md., April 26, 2017 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ:OPGN) today reported financial and operational results for the first quarter ended March 31, 2017 and summarized recent...
25 avr. 2017 08h00 HE | Source: OpGen, Inc.

OpGen Highlights Capabilities of its Acuitas® Technologies to Rapidly Predict Antibiotic Susceptibility Using Drug Resistance Gene Profiles at ECCMID

GAITHERSBURG, Md., April 25, 2017 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ:OPGN) today announced that it has presented preliminary results supporting its Acuitas Rapid Test in development to detect...
19 avr. 2017 16h15 HE | Source: OpGen, Inc.

OpGen Announces Date of First Quarter 2017 Financial Results Conference Call

GAITHERSBURG, Md., April 19, 2017 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ:OPGN) today announced that it will report its first quarter 2017 financial results after close of market on Wednesday, April...
13 avr. 2017 14h38 HE | Source: OpGen, Inc.

UPDATE -- OpGen to Present Antibiotic Resistance Prediction Data at 27th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)

GAITHERSBURG, Md., April 13, 2017 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ:OPGN) today announced that five posters featuring its technologies will be presented at the 27th European Congress of...
12 avr. 2017 16h30 HE | Source: OpGen, Inc.

OpGen to Present Antibiotic Resistance Prediction Data at 25th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)

GAITHERSBURG, Md., April 12, 2017 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ:OPGN) today announced that five posters featuring its technologies will be presented at the 25th European Congress of...
23 mars 2017 16h01 HE | Source: OpGen, Inc.

OpGen Announces 2016 Fourth Quarter and Year End Financial Results

GAITHERSBURG, Md., March 23, 2017 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ:OPGN) today reported financial and operational results for the fourth quarter and year ended December 31, 2016 and...

Page précédente